KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

OCULOSAN EYE DROPS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

 

GENERIC NAME:

NAPHAZOLINE

 

MANUFACTURER:

NOVARTIS PHARMA

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

(none)

 

INDICATIONS:

Vasoconstriction, ophthalmic

 

SIDE EFFECTS:

Hyperemia, reactive

Dizziness

headache

increased sweating

nausea

nervousness

weakness

Blurred vision

large pupils

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Cardiovascular disease

Diabetes mellitus

Eye disease, serious, or infection or injury

Hypertension

Hyperthyroidism

 

ADULT DOSE:

Ophthalmic decongestant- Topical, to the conjunctiva, 1 drop of a 0.012% solution up to four times a day as needed, or 1 drop of a 0.1% solution every three to four hours as needed.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Use is not recommended.  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT